Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


30.08.2021

1 Alzheimer Dis Assoc Disord
1 Alzheimers Dement
1 Am J Geriatr Psychiatry
2 Brain
2 Curr Alzheimer Res
12 J Alzheimers Dis
4 J Biol Chem
1 J Neurochem
1 J Neurosci
1 JAMA
2 Lancet Neurol
3 Neurobiol Aging
1 Neurology
2 Neurosci Lett
2 PLoS One
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. WANG T, Guo Z, Du Y, Xiong M, et al
    Effects of Noninvasive Brain Stimulation (NIBS) on Cognitive Impairment in Mild Cognitive Impairment and Alzheimer Disease: A Meta-analysis.
    Alzheimer Dis Assoc Disord. 2021;35:278-288.
    PubMed         Abstract available


    Alzheimers Dement

  2. WANG Q, Davis PB, Gurney ME, Xu R, et al
    COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US.
    Alzheimers Dement. 2021;17:1297-1306.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  3. TALASLAHTI T, Ginters M, Kautiainen H, Vataja R, et al
    Criminal Behavior in the Four Years Preceding Diagnosis of Neurocognitive Disorder: A Nationwide Register Study in Finland.
    Am J Geriatr Psychiatry. 2021;29:657-665.
    PubMed         Abstract available


    Brain

  4. DAVILA-BOUZIGUET E, Casoliba-Melich A, Targa-Fabra G, Galera-Lopez L, et al
    Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
    Brain. 2021 Aug 23. pii: 6356505. doi: 10.1093.
    PubMed         Abstract available

  5. KHAN AR, Ottoy J, Goubran M
    Towards a comprehensive 3D mapping of tau progression in early Alzheimer's disease.
    Brain. 2021 Aug 23. pii: 6356553. doi: 10.1093.
    PubMed        


    Curr Alzheimer Res

  6. JANOUTOVA J, Kovalova M, Machaczka O, Ambroz P, et al
    Risk Factors for Alzheimer's Disease: An Epidemiological Study.
    Curr Alzheimer Res. 2021 Aug 20. pii: CAR-EPUB-117419.
    PubMed         Abstract available

  7. PATEL P, Masurkar AV
    The Relationship of Anxiety with Alzheimer's Disease: A Narrative Review.
    Curr Alzheimer Res. 2021 Aug 22. pii: CAR-EPUB-117429.
    PubMed         Abstract available


    J Alzheimers Dis

  8. QURESHI ZP, Thiel E, Nelson J, Khandker R, et al
    Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210713. doi: 10.3233/JAD-210713.
    PubMed         Abstract available

  9. WANG H, Xu Y, Ren R, Yao F, et al
    Ambulatory Blood Pressure Characteristics of Patients with Alzheimer's Disease: A Multicenter Study from China.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210679. doi: 10.3233/JAD-210679.
    PubMed         Abstract available

  10. CIOFFI F, Ibrahim Adam RH, Bansal R, Broersen K, et al
    A Review of Oxidative Stress Products and Related Genes in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD210497. doi: 10.3233/JAD-210497.
    PubMed         Abstract available

  11. YANG HJ, Lee S, Koh MJ, Lee HK, et al
    The Association of White Matter Hyperintensities with Frailty in Patients with Very Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210494. doi: 10.3233/JAD-210494.
    PubMed         Abstract available

  12. TOK S, Ahnaou A, Drinkenburg W
    Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210397. doi: 10.3233/JAD-210397.
    PubMed         Abstract available

  13. GE F, Zhu D, Tian M, Shi J, et al
    The Role of Thyroid Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210339. doi: 10.3233/JAD-210339.
    PubMed         Abstract available

  14. WIMO A, Belger M, Bon J, Jessen F, et al
    A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210303. doi: 10.3233/JAD-210303.
    PubMed         Abstract available

  15. BARTHOLD D, Gibbons LE, Marcum ZA, Gray SL, et al
    Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.
    J Alzheimers Dis. 2021 Aug 14. pii: JAD210059. doi: 10.3233/JAD-210059.
    PubMed         Abstract available

  16. TOFIQ A, Zetterberg H, Blennow K, Basun H, et al
    Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210007. doi: 10.3233/JAD-210007.
    PubMed         Abstract available

  17. ZANGROSSI A, Montemurro S, Altoe G, Mondini S, et al
    Heterogeneity and Factorial Structure in Alzheimer's Disease: A Cognitive Perspective.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210719. doi: 10.3233/JAD-210719.
    PubMed         Abstract available

  18. MOMMAERTS K, Willemse EAJ, Marchese M, Larue C, et al
    A Cystatin C Cleavage ELISA Assay as a Quality Control Tool for Determining Sub-Optimal Storage Conditions of Cerebrospinal Fluid Samples in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210741. doi: 10.3233/JAD-210741.
    PubMed         Abstract available

  19. ROBAKIS NK
    On the Nomenclature of the Alzheimer's Disease Amyloid and Its Precursor1.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD215138. doi: 10.3233/JAD-215138.
    PubMed        


    J Biol Chem

  20. LEE YH, Im E, Hyun M, Park J, et al
    Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation.
    J Biol Chem. 2021;296:100245.
    PubMed         Abstract available

  21. TALESKI G, Schuhmacher D, Su H, Sontag JM, et al
    Disturbances in PP2A methylation and one-carbon metabolism compromise Fyn distribution, neuritogenesis, and APP regulation.
    J Biol Chem. 2021;296:100237.
    PubMed         Abstract available

  22. REYES-RUIZ JM, Nakajima R, Baghallab I, Goldschmidt L, et al
    An "epitomic" analysis of the specificity of conformation-dependent, anti-Ass amyloid monoclonal antibodies.
    J Biol Chem. 2021;296:100168.
    PubMed         Abstract available

  23. SHIELDS LY, Li H, Nguyen K, Kim H, et al
    Mitochondrial fission is a critical modulator of mutant APP-induced neural toxicity.
    J Biol Chem. 2021;296:100469.
    PubMed         Abstract available


    J Neurochem

  24. CORTES-GOMEZ MA, Llorens-Alvarez E, Alom J, Del Ser T, et al
    Tau phosphorylation by glycogen synthase kinase 3beta modulates enzyme acetylcholinesterase expression.
    J Neurochem. 2021;157:2091-2105.
    PubMed         Abstract available


    J Neurosci

  25. WU M, Liu CZ, Barrall EA, Rissman RA, et al
    Unbalanced regulation of alpha7 nAChRs by Ly6h and NACHO contributes to neurotoxicity in Alzheimer's disease.
    J Neurosci. 2021 Aug 26. pii: JNEUROSCI.0494-21.2021.
    PubMed         Abstract available


    JAMA

  26. RUBIN R
    CMS Considers Controversial Alzheimer Drug Coverage.
    JAMA. 2021;326:690.
    PubMed        


    Lancet Neurol

  27. PARNETTI L, Filippo MD, Gaetani L
    A blood test for Alzheimer's disease: a step forward.
    Lancet Neurol. 2021;20:691-693.
    PubMed        

  28. THIJSSEN EH, La Joie R, Strom A, Fonseca C, et al
    Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
    Lancet Neurol. 2021;20:739-752.
    PubMed         Abstract available


    Neurobiol Aging

  29. FLEMING V, Piro-Gambetti B, Patrick A, Zammit M, et al
    Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndrome.
    Neurobiol Aging. 2021;107:118-127.
    PubMed         Abstract available

  30. WISSE LEM, Ungrady MB, Ittyerah R, Lim SA, et al
    Cross-sectional and longitudinal medial temporal lobe subregional atrophy patterns in semantic variant primary progressive aphasia.
    Neurobiol Aging. 2021;98:231-241.
    PubMed         Abstract available

  31. GUO C, Zhang Y, Nie Q, Cao D, et al
    SQSTM1/ p62 oligomerization contributes to Abeta-induced inhibition of Nrf2 signaling.
    Neurobiol Aging. 2021;98:10-20.
    PubMed         Abstract available


    Neurology

  32. SANDERS AE
    A Century-Old Problem: Cognition and Neuropsychiatric Symptoms in Alzheimer Disease.
    Neurology. 2021 Aug 20. pii: WNL.0000000000012616.
    PubMed        


    Neurosci Lett

  33. ZHAO N, Xu B
    The beneficial effect of exercise against Alzheimer's disease may result from improved brain glucose metabolism.
    Neurosci Lett. 2021 Aug 18:136182. doi: 10.1016/j.neulet.2021.136182.
    PubMed         Abstract available

  34. WEI X, Xie L, Du P, Zhao Z, et al
    Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease.
    Neurosci Lett. 2021 Aug 23:136196. doi: 10.1016/j.neulet.2021.136196.
    PubMed         Abstract available


    PLoS One

  35. LEE SH, Chen YH, Chien CC, Yan YH, et al
    Three month inhalation exposure to low-level PM2.5 induced brain toxicity in an Alzheimer's disease mouse model.
    PLoS One. 2021;16:e0254587.
    PubMed         Abstract available

  36. SAKUTA S, Hashimoto M, Ikeda M, Koyama A, et al
    Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?
    PLoS One. 2021;16:e0247184.
    PubMed         Abstract available


    Science

  37. SERVICK K
    Alzheimer's drug approval spotlights blood tests.
    Science. 2021;373:373-374.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: